Publications

These publications were authored or co-authored by Quest Diagnostics staff.

Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR

Authors: Rogers AA, Baumann RE, Borillo GA, Kagan RM, Batterman HJ, Galdzicka M, Marlowe EM
J Clin Microbiol. 2020 Apr 27;JCM.00708-20. doi: 10.1128/JCM.00708-20. [Epub ahead of print]

Specialties: Infectious Disease

Read the Key Summary (Download PDF)

Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation.

Authors: Haller F, Moskalev EA, Kuck S, Bieg M, Winkelmann C, Müller SK, Ihrler S, Märkl B, Eils R, Wiemann S, Iro H, Hartmann A, Agaimy A.
Am J Surg Pathol. 2020 Apr. doi: 10.1097/PAS.0000000000001494. [Epub ahead of print]

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

[Inflammatory dermatoses].

Authors: Mentzel T, Bierhoff E.
Pathologe. 2020 Apr doi: 10.1007/s00292-020-00787-8. [Epub ahead of print]

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

Gaps in Dyslipidemia Care Among Working-Aged Individuals With Employer-Sponsored Health Care.

Authors: Shiffman D, Louie JZ, Devlin JJ, Knowles JW, McPhaul MJ
J Am Heart Assoc. 2020 May 5;9:e015807. doi: 10.1161/JAHA.119.015807. Epub 2020 Apr 22.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Read the Key Summary (Download PDF)

Prevalence of Suspected Direct Oral Anticoagulant Interference on Thrombophilia Testing at a US National Reference Laboratory.

Authors: Wong ECC, Worfolk LA, Sahud M, Dlott JS.
Clin Chem. 2020 Apr 66:618-620. doi: 10.1093/clinchem/hvaa044.

Specialties: Hematology/Hemostasis/Thrombosis

Bilateral pulmonary metastases of papillary thyroid carcinoma in a 12-year-old child-A case report and review of the literature.

Authors: Thirumala V, O'Souji C, Thirumala S.
Radiol Case Rep. 2020 Apr;15:799-802. doi: 10.1016/j.radcr.2020.03.022. eCollection 2020 Jun.

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath, a subsidiary of Quest Diagnostics.

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice.

Authors: Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, Reisenbichler E, Kos Z, Carter JM, Michiels S, Le Quesne J, Nielsen TO, Laenkholm AV, Fox SB, Adam J, Bartlett JM, Rimm DL, Quinn C, Peeters D, Dieci MV, Vincent-Salomon A, Cree I, Hida AI, Balko JM, Haynes HR, Frahm I, Acosta-Haab G, Balancin M, Bellolio E, Yang W, Kirtani P, Sugie T, Ehinger A, Castaneda CA, Kok M, McArthur H, Siziopikou K, Badve S, Fineberg S, Gown A, Viale G, Schnitt SJ, Pruneri G, Penault-Llorca F, Hewitt S, Thompson EA, Allison KH, Symmans WF, Bellizzi AM, Brogi E, Moore DA, Larsimont D, Dillon DA, Lazar A, Lien H, Goetz MP, Broeckx G, El Bairi K, Harbeck N, Cimino-Mathews A, Sotiriou C, Adams S, Liu SW, Loibl S, Chen IC, Lakhani SR, Juco JW, Denkert C, Blackley EF, Demaria S, Leon-Ferre R, Gluz O, Zardavas D, Emancipator K, Ely S, Loi S, Salgado R, Sanders M; International Immuno-Oncology Biomarker Working Group.
J Pathol. 2020 Apr;250:667-684. doi: 10.1002/path.5406. Epub 2020 Apr 9.

Specialties: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.

Reply to 'Comment on "Histopathologic features distinguishing secondary syphilis from its mimickers".

Authors: Flamm A, Alcocer VM, Kazlouskaya V, Kwon EJ, Elston D.
J Am Acad Dermatol. 2020 Apr. pii: S0190-9622(20)30531-4. doi: 10.1016/j.jaad.2020.03.106. [Epub ahead of print]

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease.

Authors: Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Garbe C, Berking C.
J Dtsch Dermatol Ges. 2020 Apr;18:400-413. doi: 10.1111/ddg.14072. Epub 2020 Apr 4.

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.

Authors: Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky JB, Shi CJ, Giannico GA.
Histopathology. 2020 Mar;76:550-559. doi: 10.1111/his.14012. Epub 2020 Jan 24.

Specialties: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.